TrialBritish journal of cancer2018

Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study.

David K Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.